Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P47989 (
xanthine oxidase
)
8,633
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mechanisms of context-specific differences in signal transduction, such as those that occur among different cell types, are not fully understood. One possibility is that differences in the abundance of proteins change signaling outputs because these proteins compete for binding to hub proteins at critical network branch points. Focusing on the ErbB signaling, we created a protein interaction network that included information about protein domains and analyzed the role of competing protein interactions. By leveraging three-dimensional protein structures to infer steric interactions among binding partners for a common binding domain or linear motif (node) and including information about protein abundance and interaction affinities, we identified a large number of competitive, mutually exclusive (
XOR
) protein interactions. Modeling changes in protein abundance with different patterns of partner proteins and
XOR
nodes (
XOR
motifs) revealed that each motif conferred a different response. We experimentally investigated the
XOR
motif containing the hub protein Ras and its binding partners
RIN1
(Ras and Rab interactor 1) and CRAF (v-raf-leukemia viral oncogene 1). Consistent with the computational prediction, overexpression of
RIN1
in cultured cells decreased the phosphorylation of CRAF and its downstream targets. Thus, our analyses provide evidence that variation in the abundance of proteins that compete for binding to
XOR
nodes could contribute to context-specific signaling plasticity.
...
PMID:Integration of protein abundance and structure data reveals competition in the ErbB signaling network. 2434 80